Alzex Neuropharma Inc. (TRRI)

OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Feb 6, 2026
-99.85%
Market Cap 452.00
Revenue (ttm) 4.73M
Net Income (ttm) 32.05K
Shares Out 1.51M
EPS (ttm) n/a
PE Ratio 0.01
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 113
Average Volume 2,132
Open 0.0003
Previous Close 0.0003
Day's Range 0.0003 - 0.0003
52-Week Range 0.0002 - 0.1980
Beta -53.60
RSI 42.26
Earnings Date n/a

About Alzex Neuropharma

Alzex Neuropharma Inc., a development stage biopharmaceutical company, engages in developing therapeutics for the treatment of Alzheimer's Disease and other neurological diseases. The company was formerly known as Trinity Resources Inc. and changed its name to Alzex Neuropharma Inc. in December 2022. The company was incorporated in 1971 and is headquartered in Las Vegas, Nevada. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1971
Employees 11
Stock Exchange OTCMKTS
Ticker Symbol TRRI
Full Company Profile

Financial Performance

In 2011, Alzex Neuropharma's revenue was $4.73 million, an increase of 23.83% compared to the previous year's $3.82 million. Earnings were $32,053, a decrease of -59.83%.

Financial Statements

News

There is no news available yet.